目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED & REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Approach 1: Company revenue estimation approach
2.2.1.2 Approach 2: Presentations of companies and primary interviews
2.2.1.3 Growth forecast
2.2.2 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 RESEARCH ASSUMPTIONS
2.5.1 PARAMETRIC ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 FOLEY CATHETERS MARKET OVERVIEW
4.2 EUROPE: FOLEY CATHETERS MARKET, BY END USER AND COUNTRY (2024)
4.3 GEOGRAPHICAL GROWTH OPPORTUNITIES IN FOLEY CATHETERS MARKET
4.4 FOLEY CATHETERS MARKET: GEOGRAPHICAL MIX
4.5 FOLEY CATHETERS MARKET: EMERGING VS. DEVELOPED ECONOMIES

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing prevalence of urological disorders
5.2.1.2 Increasing surgical volumes and ICU admissions
5.2.1.3 Rapid growth in global geriatric population
5.2.1.4 Shift toward post-acute and home-based care
5.2.2 RESTRAINTS
5.2.2.1 Patient discomfort and stigma
5.2.2.2 Growing preference for alternative catheterization methods
5.2.3 OPPORTUNITIES
5.2.3.1 Innovation in catheter design and material composition
5.2.3.2 Development of smart Foley catheters
5.2.3.3 Increasing healthcare infrastructure in emerging markets
5.2.4 CHALLENGES
5.2.4.1 High risk of catheter-associated urinary tract infections (CAUTIs)
5.2.4.2 Improper insertion or maintenance of Foley catheters
5.3 PRICING ANALYSIS
5.3.1 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYERS, 2022-2024
5.3.2 AVERAGE SELLING PRICE TREND, BY REGION 2022-2024
5.3.3 AVERAGE SELLING PRICE TREND, BY TIP TYPE, 2022-2024
5.3.4 AVERAGE SELLING PRICE TREND, BY COATING TYPE, 2022-2024
5.4 VALUE CHAIN ANALYSIS
5.4.1 RESEARCH & DEVELOPMENT
5.4.2 RAW MATERIAL SUPPLIERS
5.4.3 MANUFACTURING
5.4.4 DISTRIBUTION
5.4.5 MARKETING & SALES
5.4.6 POST-SALES SERVICES
5.5 SUPPLY CHAIN ANALYSIS
5.5.1 PROMINENT COMPANIES
5.5.2 SMALL & MEDIUM-SIZED ENTERPRISES
5.5.3 END USERS
5.6 ECOSYSTEM ANALYSIS
5.7 TECHNOLOGY ANALYSIS
5.7.1 KEY TECHNOLOGIES
5.7.1.1 Antimicrobial coating technologies
5.7.1.2 Hydrophilic technology
5.7.2 COMPLEMENTARY TECHNOLOGIES
5.7.2.1 Smart catheters
5.7.2.2 Catheter securement devices
5.8 PORTER'S FIVE FORCES ANALYSIS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF SUPPLIERS
5.8.4 BARGAINING POWER OF BUYERS
5.8.5 INTENSITY OF COMPETITIVE RIVALRY
5.9 REGULATORY ANALYSIS
5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.9.2 REGULATORY LANDSCAPE
5.9.2.1 North America
5.9.2.1.1 US
5.9.2.1.2 Canada
5.9.2.2 Europe
5.9.2.2.1 Germany
5.9.2.2.2 UK
5.9.2.2.3 France
5.9.2.2.4 Italy
5.9.2.2.5 Spain
5.9.2.3 Asia Pacific
5.9.2.3.1 China
5.9.2.3.2 Japan
5.9.2.3.3 India
5.9.2.4 Latin America
5.9.2.4.1 Brazil
5.9.2.4.2 Mexico
5.9.2.5 Middle East
5.9.2.6 Africa
5.10 PATENT ANALYSIS
5.11 TRADE ANALYSIS
5.11.1 IMPORT DATA FOR HS CODE 901839
5.11.2 EXPORT DATA FOR HS CODE 901839
5.12 KEY CONFERENCES & EVENTS, 2025-2026
5.13 CASE STUDY ANALYSIS
5.13.1 CASE STUDY 1: APPROPRIATE USE OF INDWELLING URINARY CATHETERS REDUCES RISK OF CAUTI
5.13.2 CASE STUDY 2: DECREASE IN FOLEY CATHETER UTILIZATION RATES IMPROVES PATIENT CARE IN AN INTENSIVE CORONARY CARE UNIT
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.15 KEY STAKEHOLDERS & BUYING CRITERIA
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.15.2 BUYING CRITERIA
5.16 INVESTMENT & FUNDING SCENARIO
5.17 IMPACT OF AI/GENERATIVE AI ON FOLEY CATHETERS MARKET
5.17.1 INTRODUCTION
5.17.2 POTENTIAL OF AI IN FOLEY CATHETERS MARKET
5.17.3 AI USE CASES
5.17.4 KEY COMPANIES IMPLEMENTING AI
5.17.5 FUTURE OF GENERATIVE AI IN FOLEY CATHETERS MARKET
5.18 IMPACT OF 2025 US TARIFFS ON FOLEY CATHETERS MARKET
5.18.1 INTRODUCTION
5.18.2 KEY TARIFF RATES
5.18.3 IMPACT OF TARIFFS ON PRICING
5.18.4 IMPACT ON REGIONS
5.18.4.1 North America
5.18.4.2 Europe
5.18.4.3 Asia Pacific
5.18.5 END-USER INDUSTRY IMPACT

6 FOLEY CATHETERS MARKET, BY INSERTION TYPE
6.1 INTRODUCTION
6.2 URETHRAL CATHETERS
6.2.1 GROWING BURDEN OF UROLOGIC CANCERS TO DRIVE MARKET GROWTH
6.3 SUPRAPUBIC CATHETERS
6.3.1 REDUCED INCIDENCE OF CATHETER-ASSOCIATED URINARY TRACT INFECTIONS (CAUTIS) TO DRIVE DEMAND

7 FOLEY CATHETERS MARKET, BY FRENCH SIZE
7.1 INTRODUCTION
7.2 12FR AND BELOW
7.2.1 INCREASING FOCUS ON PEDIATRIC UROLOGY AND NEONATAL INTENSIVE CARE TO DRIVE MARKET GROWTH
7.3 14FR
7.3.1 INCREASING BURDEN OF CHRONIC DISEASES TO SUPPORT MARKET GROWTH
7.4 16FR
7.4.1 GROWING GERIATRIC POPULATION AND INCREASING INCIDENCE OF CHRONIC CONDITIONS TO BOOST MARKET
7.5 18FR
7.5.1 GROWING PREVALENCE OF URINARY INCONTINENCE TO BOOST MARKET
7.6 20FR AND ABOVE
7.6.1 RISING INCIDENCE OF GENITOURINARY MALIGNANCIES TO DRIVE MARKET GROWTH

8 FOLEY CATHETERS MARKET, BY TIP TYPE
8.1 INTRODUCTION
8.2 STRAIGHT-TIPPED CATHETERS
8.2.1 INCREASING INCIDENCE OF POSTOPERATIVE URINARY RETENTION TO PROPEL DEMAND
8.3 COUDE-TIPPED CATHETERS
8.3.1 GROWING PREVALENCE OF BENIGN PROSTATIC HYPERPLASIA (BHP) TO SUPPORT MARKET GROWTH
8.4 OTHER-TIPPED CATHETERS

9 FOLEY CATHETERS MARKET, BY BALLOON SIZE
9.1 INTRODUCTION
9.2 5 ML BALLOONS
9.2.1 PROVISION OF SECURE BLADDER ANCHORAGE TO DRIVE DEMAND
9.3 10 ML BALLOONS
9.3.1 AGING POPULATION TO FUEL DEMAND FOR 10 ML BALLOONS
9.4 OTHER BALLOON SIZES

10 FOLEY CATHETERS MARKET, BY LUMEN NUMBER
10.1 INTRODUCTION
10.2 2-WAY
10.2.1 INCREASING INCIDENCE OF NEUROGENIC BLADDER DISORDERS TO DRIVE DEMAND FOR 2-WAY CATHETERS
10.3 3-WAY & 4-WAY
10.3.1 INCREASING INCIDENCE OF BLADDER CANCER TO DRIVE GROWTH

11 FOLEY CATHETERS MARKET, BY MATERIAL
11.1 INTRODUCTION
11.2 LATEX FOLEY CATHETERS
11.2.1 COST-EFFECTIVENESS OF LATEX TO PROPEL DEMAND
11.3 SILICONE FOLEY CATHETERS
11.3.1 REDUCED RISK OF ALLERGIC REACTIONS ASSOCIATED WITH SILICONE CATHETERS TO SUPPORT MARKET GROWTH
11.4 HYBRID FOLEY CATHETERS
11.4.1 ADVANCEMENTS IN COATING TECHNOLOGIES TO DRIVE ADOPTION

12 FOLEY CATHETERS MARKET, BY COATING TYPE
12.1 INTRODUCTION
12.2 ANTIMICROBIAL-COATED FOLEY CATHETERS
12.2.1 HIGH INCIDENCE OF CATHETER-ASSOCIATED URINARY TRACT INFECTIONS TO DRIVE DEMAND
12.3 HYDROPHILIC OR LUBRICATION-COATED FOLEY CATHETERS
12.3.1 INCREASING FOCUS ON PATIENT SAFETY AND COMFORT TO SUPPORT MARKET GROWTH
12.4 UNCOATED FOLEY CATHETERS
12.4.1 INCREASING DEMAND DUE TO AFFORDABILITY AND ACCESSIBILITY TO DRIVE MARKET GROWTH

13 FOLEY CATHETERS MARKET, BY GENDER
13.1 INTRODUCTION
13.2 MALES
13.2.1 INCREASING INCIDENCE OF KIDNEY, PROSTATE, AND BLADDER CANCERS AMONG MEN TO BOOST MARKET GROWTH
13.3 FEMALES
13.3.1 INCREASING PREVALENCE OF URINARY INCONTINENCE TO DRIVE MARKET GROWTH

14 FOLEY CATHETERS MARKET, BY END USER
14.1 INTRODUCTION
14.2 HOSPITALS & ASCS
14.2.1 HIGH VOLUME OF SURGICAL PROCEDURES TO DRIVE DEMAND
14.3 LONG-TERM CARE FACILITIES
14.3.1 EXPANSION OF LONG-TERM CARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
14.4 OTHER END USERS

15 FOLEY CATHETERS MARKET, BY REGION
15.1 INTRODUCTION
15.2 EUROPE
15.2.1 MACROECONOMIC OUTLOOK FOR EUROPE
15.2.2 GERMANY
15.2.2.1 Growing incidence of urinary incontinence to propel demand
15.2.3 UK
15.2.3.1 Well-established healthcare infrastructure to accelerate demand
15.2.4 FRANCE
15.2.4.1 Large target population to support market growth
15.2.5 ITALY
15.2.5.1 Increasing prevalence of urological conditions to drive the demand
15.2.6 SPAIN
15.2.6.1 Rising prevalence of chronic disorders to drive market growth
15.2.7 REST OF EUROPE
15.3 NORTH AMERICA
15.3.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
15.3.2 US
15.3.2.1 Rising prevalence of conditions such as benign prostatic hyperplasia (BPH) to drive demand
15.3.3 CANADA
15.3.3.1 Substantial investment in healthcare infrastructure to drive demand
15.4 ASIA PACIFIC
15.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
15.4.2 CHINA
15.4.2.1 Rapidly increasing elderly population to boost demand
15.4.3 JAPAN
15.4.3.1 Presence of established healthcare system and favorable reimbursements to drive market
15.4.4 INDIA
15.4.4.1 Rising incidence of cancers to drive demand
15.4.5 REST OF ASIA PACIFIC
15.5 LATIN AMERICA
15.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
15.5.2 BRAZIL
15.5.2.1 Rising prevalence of cancer to drive demand
15.5.3 MEXICO
15.5.3.1 Rising geriatric population to drive demand
15.5.4 REST OF LATIN AMERICA
15.6 MIDDLE EAST & AFRICA
15.6.1 IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
15.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA

16 COMPETITIVE LANDSCAPE
16.1 OVERVIEW
16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
16.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN FOLEY CATHETERS MARKET
16.3 REVENUE ANALYSIS, 2022-2024
16.4 MARKET SHARE ANALYSIS, 2024
16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
16.5.1 STARS
16.5.2 EMERGING LEADERS
16.5.3 PERVASIVE PLAYERS
16.5.4 PARTICIPANTS
16.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
16.5.5.1 Company footprint
16.5.5.2 Region footprint
16.5.5.3 Insertion type footprint
16.5.5.4 Coating type footprint
16.5.5.5 End-user footprint
16.6 COMPANY EVALUATION MATRIX: SMES/STARTUPS, 2024
16.6.1 PROGRESSIVE COMPANIES
16.6.2 RESPONSIVE COMPANIES
16.6.3 DYNAMIC COMPANIES
16.6.4 STARTING BLOCKS
16.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
16.6.5.1 Detailed list of key startups/SMEs
16.6.5.2 Competitive benchmarking of key emerging players/startups
16.7 COMPANY VALUATION & FINANCIAL METRICS
16.8 BRAND/PRODUCT COMPARISON
16.9 COMPETITIVE SCENARIO
16.9.1 PRODUCT LAUNCHES & APPROVALS
16.9.2 DEALS
16.9.3 EXPANSIONS

17 COMPANY PROFILES
17.1 KEY PLAYERS
17.1.1 COLOPLAST A/S
17.1.1.1 Business overview
17.1.1.2 Products offered
17.1.1.3 Recent developments
17.1.1.3.1 Expansions
17.1.1.4 MnM view
17.1.1.4.1 Key strengths
17.1.1.4.2 Strategic choices
17.1.1.4.3 Weaknesses & competitive threats
17.1.2 BECTON, DICKINSON AND COMPANY
17.1.2.1 Business overview
17.1.2.2 Products offered
17.1.2.3 Recent developments
17.1.2.3.1 Deals
17.1.2.4 MnM view
17.1.2.4.1 Key strengths
17.1.2.4.2 Strategic choices
17.1.2.4.3 Weaknesses & competitive threats
17.1.3 TELEFLEX INCORPORATED
17.1.3.1 Business overview
17.1.3.2 Products offered
17.1.3.3 MnM view
17.1.3.3.1 Key strengths
17.1.3.3.2 Strategic choices
17.1.3.3.3 Weaknesses & competitive threats
17.1.4 CARDINAL HEALTH, INC.
17.1.4.1 Business overview
17.1.4.2 Products offered
17.1.4.3 Recent developments
17.1.4.3.1 Expansions
17.1.4.4 MnM view
17.1.4.4.1 Key strengths
17.1.4.4.2 Strategic choices
17.1.4.4.3 Weaknesses & competitive threats
17.1.5 B. BRAUN SE
17.1.5.1 Business overview
17.1.5.2 Products offered
17.1.5.3 MnM view
17.1.5.3.1 Key strengths
17.1.5.3.2 Strategic choices
17.1.5.3.3 Weaknesses & competitive threats
17.1.6 MEDLINE INDUSTRIES, LP
17.1.6.1 Business overview
17.1.6.2 Products offered
17.1.6.3 Recent developments
17.1.6.3.1 Deals
17.1.6.3.2 Expansions
17.1.7 MEDTRONIC PLC
17.1.7.1 Business overview
17.1.7.2 Products offered
17.1.8 STERIMED GROUP
17.1.8.1 Business overview
17.1.8.2 Products offered
17.1.9 AMSINO INTERNATIONAL, INC.
17.1.9.1 Business overview
17.1.9.2 Products offered
17.1.9.3 Recent developments
17.1.9.3.1 Product launches
17.1.9.3.2 Expansions
17.1.10 BACTIGUARD AB
17.1.10.1 Business overview
17.1.10.2 Products offered
17.1.10.3 Recent developments
17.1.10.3.1 Product approvals
17.1.11 MCKESSON CORPORATION
17.1.11.1 Business overview
17.1.11.2 Products offered
17.2 OTHER PLAYERS
17.2.1 ADVACARE PHARMA
17.2.2 ANGIPLAST PRIVATE LIMITED
17.2.3 OPTIMUM MEDICAL LIMITED
17.2.4 SUZHOU SUNMED CO., LTD.
17.2.5 WELL LEAD MEDICAL CO., LTD.
17.2.6 POLYMED
17.2.7 HEMC (HOSPITAL EQUIPMENT MANUFACTURING COMPANY)
17.2.8 HANGZHOU FORMED MEDICAL DEVICES CO., LTD.
17.2.9 RWD LIFE SCIENCE CO., LTD.
17.2.10 PENNINE HEALTHCARE
17.2.11 GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.
17.2.12 GPC MEDICAL LTD.
17.2.13 ADVIN HEALTH CARE
17.2.14 RIBBEL INTERNATIONAL LTD.
17.2.15 HANDAN FCH MEDICAL TECHNOLOGY CO., LTD.

18 APPENDIX
18.1 DISCUSSION GUIDE
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
18.3 CUSTOMIZATION OPTIONS
18.4 RELATED REPORTS
18.5 AUTHOR DETAILS